Specificity, or the true negative rate, measures the proportion of non-cancer cases that are correctly identified by the diagnostic test. It answers the question: "If a person does not have cancer, how often will the test be negative?" High specificity is essential to minimize false positives, which can lead to unnecessary anxiety and further invasive testing.
